Проф. д-р Серкан Кескин - визитка

Prof. Dr. Serkan Keskin

Prof. Dr. Serkan Keskin

BRIEF INFORMATION:
Specialist:
medical oncologist

CV and professional development

Education

  • 2009 – 2013 – Institute of Oncology, Istanbul University, Turkey
  • 2002 – 2006 – Taksim Educational and Research Hospital, Istanbul, Turkey
  • 1995 – 2001 – Faculty of Medicine, Trakya University, Edirne, Turkey

Professional experience

  • 2015 – Present – Medical Oncologist, Memorial Şişli Hospital, Istanbul
  • 2013 – 2015 – Medical Oncologist, Okmeydanı Training and Research Hospital, Istanbul
  • 2006 – 2009 – Internal Medicine Specialist, Başakşehir State Hospital, Istanbul

Memberships and publications

Memberships

  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology (ESMO)
  • Turkish Society of Internal Medicine
  • Turkish Society of Medical Oncology
  • Society of Clinical Oncology

Scientific activity

  • 42 scientific articles in international peer-reviewed journals
  • 16 reports presented at international scientific forums
  • 12 articles in national peer-reviewed journals
  • 46 presentations at national scientific conferences
  • Lecturer at numerous medical congresses

Training and participation in congresses

  • National Oncology Congress
  • Medical Oncology Congresses
  • American Society of Clinical Oncology (ASCO) Meetings and Training
  • European Society for Medical Oncology (ESMO) Congresses and Educational Courses

Clinical areas of interest

Prof. Dr. Serkan Keskin is a specialist with many years of clinical and scientific experience. His professional interests are focused on modern treatment of oncological diseases through chemotherapy, immunotherapy, targeted therapy, and a personalized approach with the application of so-called „smart drugs“. He specializes in the treatment of both solid tumors and hematological oncological diseases.

Breast cancer
Gynecologic oncologic diseases
• Lung carcinoma
Bladder cancer
Metastatic tumors
Sarcomas and melanomas
Neuroendocrine tumors
Adrenal gland cancer

Additional areas

  • Treatment of metastatic tumors
  • Tracking patients with advanced cancer
  • Palliative care and symptom management

Additional information

Проф. д-р Серкан Кескин 01

"The oral or intravenous administration of the right drug for the disease in a cancer patient alone cannot be considered a success. The secret lies in love and respect for the person. The effort to inspire hope, as well as the trust of the patient himself and his family, are also integral to successful treatment."
Prof. Dr. Serkan Keskin

Prof. Dr. Keskin combines the high-tech methods of modern oncology with a deeply humane approach to the patient. His practice is based on innovative, personalized therapies that increase treatment effectiveness and minimize side effects.

Methods of treatment

Tumor genetic mapping

An innovative method that allows the selection of the most appropriate individual treatment by analyzing cancer cells in a blood or tissue sample. Unlike genetic testing, which assesses inherited risk, mapping aims for effective therapy based on the structure and behavior of the tumor itself.

Targeted therapy with „smart drugs“

A modern method where medications are applied directly to tumor cells without damaging healthy tissues. Thanks to genetic mapping information, the most suitable medication is selected.
Smart drugs can be:

  • With small molecules penetrate the interior of the tumor cell
  • With large molecules - attack the cell from the outside using guiding agents

Suitable for treating:

  • Chronic leukemias
  • Breast cancer
  • Colorectal cancer
  • Head and neck tumors
  • Other solid tumors, depending on mapping results

Chemotherapy

A classic, yet still effective method for the systemic treatment of cancerous diseases. It is used alone or in combination with targeted therapy and immunotherapy.

Immunotherapy (biological therapy)

A modern approach that activates the patient's own immune system to recognize and destroy cancer cells.

  • Suitable for: mild to moderate stages, patients with genetic mutations, advanced cases
  • Administered by intravenous infusion every 2-3 weeks
  • Often used for: bladder cancer, brain tumors, breast cancer, cervical cancer, ovarian cancer, colon cancer, kidney cancer, liver cancer, lung cancer, prostate cancer, leukemias, lymphomas

Advantages of modern therapies

  • Fewer side effects
  • Better patient tolerance
  • Longer progression-free survival
  • Higher quality of life during treatment

Clinical data show that in patients undergoing targeted therapy, progression-free survival reaches 11 months – almost twice as much, than with standard chemotherapy.

Work streams:

Part of the team:

Група болници Мемориал превю

Memorial Hospitals Group

Memorial Healthcare Group , with excellent staff and a customer-centric concept of service delivery in the light of ethical principles of international quality standards, with creating a difference in the medical sector with leading healthcare practices was established with the mission to become a global brand for quality and innovation worldwide. Memorial is the first in Turkey and 21st among hospitals in the world to receive the JCI (Joint Commission International ) Quality Accreditation Certificate.

Last viewed in section
"Doctors."

Prof. Dr. Ali Aycan Kavala
Prof. Dr. Meriem Jan
Prof. Dr. Manuel Garcia de Lomas Barrionuevo
Dr. Güray Öztürk
Prof. Dr. Georg Schatzl
Our offices at home and abroad:

Head office Sofia:

Str. General Ivan Kolev, 33 B Bulgaria, Sofia

Plovdiv office:

Blvd. Hristo Botev 92, RILON Business Centre, floor 2 Bulgaria, Plovdiv

Plovdiv Province

Smolyan Province:

Office Burgas:

Str. Ivan Vazov 75 Bulgaria, Burgas 8000

Stara Zagora Office:

2 Zachary Knyazheski Street,
Bulgaria, Stara Zagora

Shumen Office:

Str. Panayot Volov No.2 Bulgaria, Shumen.

Macedonia Office:

Bane Andreev Ronkata #2, 1400 Veles, Macedonia